Last reviewed · How we verify
Ginger powder capsule
At a glance
| Generic name | Ginger powder capsule |
|---|---|
| Also known as | zintoma |
| Sponsor | Cairo University |
| Modality | Small molecule |
| Phase | Phase 3 |
Approved indications
Common side effects
Key clinical trials
- A Single Group Study to Evaluate the Efficacy of Bye Bye Bloat Capsules in Relieving Bloating and Promoting Healthy Digestion. (NA)
- the Efficacy of Ginger Powder as an Analgesic for Intraoperative and Post- Endodontic Pain Management (PHASE3)
- A Study of Biological Effects of a Polyphenol Supplement (NA)
- Prokinetic Effect of Selected Nutraceuticals (NA)
- Effects of a Novel Supplement on Glycemic Variability Measured by Continuous Glucose Monitoring (NA)
- Impact of Ginger on Menopausal Symptoms (NA)
- Efficacy of Ginger on Intraoperative and Postoperative Nausea and Vomiting in Elective Cesarean Section Patients (PHASE2, PHASE3)
- Effects of Ginger on Nonalcoholic Fatty Liver Disease in T2DM (EARLY_PHASE1)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Ginger powder capsule CI brief — competitive landscape report
- Ginger powder capsule updates RSS · CI watch RSS
- Cairo University portfolio CI